(Circulation. 1997;96:3696-3703.)
© 1997 American Heart Association, Inc.
Articles |
From the Department of Circulation (J.T., K.K., J.C., J.K.L.) and the Department of Humoral Regulation (R.S., I.K.), Research Institute of Environmental Medicine, Nagoya (Japan) University.
Correspondence to Kaichiro Kamiya, MD, Department of Circulation, Research Institute of Environmental Medicine, Nagoya University, Furo-cho, Chikusa-ku, Nagoya, 46401 Japan.
Background Methanesulfonanilide derivatives, selective inhibitors of the rapidly activating component (IKr) of the delayed rectifier potassium current (IK), prolong action potential duration (APD) of cardiac muscles with reverse frequency dependence, which limits their clinical use because of proarrhythmia. Vesnarinone, a quinolinone derivative developed as a cardiotonic agent, has complex pharmacological properties, but its clinical efficacy is explained in part by IK reduction. Therefore, we investigated the mode of IK block by vesnarinone.
Methods and Results IK of the rabbit ventricular myocyte was activated by voltage-clamp steps applied from a holding potential to various depolarizing levels. The development of IK block at depolarization (+10 mV) and its recovery process at hyperpolarization (-75 mV) were compared between vesnarinone and E-4031. The IK block by vesnarinone (3 µmol/L) developed and recovered monoexponentially, with time constants of 361 ms (n=5) and 1.87 seconds (n=4), respectively. IK block by E-4031 (0.3 µmol/L) developed instantaneously, with no recovery from the block at hyperpolarization. The IK block by vesnarinone, estimated by IK tail after a train of depolarizing pulses (for 30 seconds at 0.2 to 2 Hz), was increased with increasing frequency (twofold at 2 from 0.2 Hz), but that by E-4031 was unchanged. In rabbit papillary muscles, vesnarinone (10 µmol/L) prolonged APD at stimulation frequencies >0.2 Hz, whereas E-4031 (0.3 µmol/L) prolonged that in a reverse frequency-dependent manner.
Conclusions Vesnarinone may prolong the repolarization of human cardiac muscle without reverse frequency dependence, because IKr is expressed in humans as well as in the rabbit. Thus, this drug may be a model for an ideal class III drug without the risk of proarrhythmia.
Key Words: arrhythmia potassium channels action potentials
This article has been cited by other articles:
![]() |
K. Tsujimae, S. Suzuki, S. Murakami, and Y. Kurachi Frequency-dependent effects of various IKr blockers on cardiac action potential duration in a human atrial model Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H660 - H669. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Lu, K. Kamiya, T. Opthof, K. Yasui, and I. Kodama Density and Kinetics of IKr and IKs in Guinea Pig and Rabbit Ventricular Myocytes Explain Different Efficacy of IKs Blockade at High Heart Rate in Guinea Pig and Rabbit: Implications for Arrhythmogenesis in Humans Circulation, August 21, 2001; 104(8): 951 - 956. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kamiya, J. S. Mitcheson, K. Yasui, I. Kodama, and M. C. Sanguinetti Open Channel Block of HERG K+ Channels by Vesnarinone Mol. Pharmacol., August 1, 2001; 60(2): 244 - 253. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Katayama, A. Fujita, T. Ohe, I. Findlay, and Y. Kurachi Inhibitory Effects of Vesnarinone on Cloned Cardiac Delayed Rectifier K+ Channels Expressed in a Mammalian Cell Line J. Pharmacol. Exp. Ther., July 1, 2000; 294(1): 339 - 346. [Abstract] [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |